HEMLIBRA® is a therapeutic bispecific monoclonal antibody

How HEMLIBRA works

HEMLIBRA bridges FIXa and FX to restore the function of missing FVIIIa needed for effective hemostasis

HEMLIBRA does not cause or increase FVIII inhibitors and remains active in their presence.

FIXa=activated factor IX; FX=factor X; FVIIIa=activated factor VIII.

HEMLIBRA Webcast

Stay up-to-date with informative webcast events

HEMLIBRA Dosing

Calculate the dosage for your HEMLIBRA patient